Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Mintz

Showing results (131-140 of 275) with videos related to

Pageof 28
Sort By:
Sleep|July 25, 2016
Prevalence, Correlates, and Predictors of Insomnia in the US Army prior to DeploymentDaniel J Taylor, Kristi E Pruiksma, Willie J Hale, et al.
The American Journal of Psychiatry|August 6, 2003
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomesStephen R Marder, Shirley M Glynn, William C Wirshing, et al.
Bipolar Disorders|January 13, 2009
Conceptualizing impulsivity and risk taking in bipolar disorder: importance of history of alcohol abuseM Kathleen Holmes, Carrie E Bearden, Marcela Barguil, et al.
Neurochemical Research|May 8, 2007
Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implicationsGeorge Bartzokis, Po H Lu, Todd A Tishler, et al.
Archives of General Psychiatry|November 7, 2002
Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the University of California, Los Angeles Family StudyRobert F Asarnow, Keith H Nuechterlein, Kenneth L Subotnik, et al.
Schizophrenia Research|July 31, 2007
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trialJonathan K Wynn, Michael F Green, Joyce Sprock, et al.
Journal of Affective Disorders|July 14, 2007
Modal subcomponents of metabolic syndrome in patients with bipolar disorderJeffrey Cardenas, Mark A Frye, Susan L Marusak, et al.
Schizophrenia Bulletin|October 13, 2007
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophreniaDawn I Velligan, Pamela M Diamond, Jim Mintz, et al.
Schizophrenia Bulletin|August 24, 2011
Neurocognitive predictors of work outcome in recent-onset schizophreniaKeith H Nuechterlein, Kenneth L Subotnik, Michael F Green, et al.
Military Medical Research|October 9, 2020
Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot studyMuhammad R Baig, Robert D Beck, Jennifer L Wilson, et al.
Pageof 28

Showing results (131-140 of 275) with videos related to

Sort By:
Pageof 28
Sleep|July 25, 2016
Prevalence, Correlates, and Predictors of Insomnia in the US Army prior to DeploymentDaniel J Taylor, Kristi E Pruiksma, Willie J Hale, et al.
The American Journal of Psychiatry|August 6, 2003
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomesStephen R Marder, Shirley M Glynn, William C Wirshing, et al.
Bipolar Disorders|January 13, 2009
Conceptualizing impulsivity and risk taking in bipolar disorder: importance of history of alcohol abuseM Kathleen Holmes, Carrie E Bearden, Marcela Barguil, et al.
Neurochemical Research|May 8, 2007
Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implicationsGeorge Bartzokis, Po H Lu, Todd A Tishler, et al.
Archives of General Psychiatry|November 7, 2002
Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the University of California, Los Angeles Family StudyRobert F Asarnow, Keith H Nuechterlein, Kenneth L Subotnik, et al.
Schizophrenia Research|July 31, 2007
Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trialJonathan K Wynn, Michael F Green, Joyce Sprock, et al.
Journal of Affective Disorders|July 14, 2007
Modal subcomponents of metabolic syndrome in patients with bipolar disorderJeffrey Cardenas, Mark A Frye, Susan L Marusak, et al.
Schizophrenia Bulletin|October 13, 2007
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophreniaDawn I Velligan, Pamela M Diamond, Jim Mintz, et al.
Schizophrenia Bulletin|August 24, 2011
Neurocognitive predictors of work outcome in recent-onset schizophreniaKeith H Nuechterlein, Kenneth L Subotnik, Michael F Green, et al.
Military Medical Research|October 9, 2020
Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot studyMuhammad R Baig, Robert D Beck, Jennifer L Wilson, et al.
Pageof 28